Memorial Sloan Kettering

Cancer hospitals like Memorial Sloan Kettering fight cancer and the coronavirus at the same time | NBC News | 5/26/2020

Coronavirus Cancer hospitals like Memorial Sloan Kettering fight cancer and the coronavirus at the same time In the age of COVID-19, cancer hospitals like Memorial Sloan Kettering have been forced to reimagine how to care for patients like 27-year-old Eliza Paris. May 26, 2020 04:24 Breaking News Emails May 26, 2020, 11:29 AM UTC / Updated May 26, 2020, 12:40 PM UTC ByKit Ramgopal, Cynthia McFadden and Kevin …

Parkinson’s disease grafts benefit from well-timed growth factor | NBC News | 5/26/2020

… has limitations. Injecting a growth factor three weeks after transplantation can overcome some of these limits. Lorenz Studer & Lorenz Studer is in the Developmental Biology Program and the Center for Stem Cell Biology, the Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. Google Scholar Viviane Tabar Viviane Tabar is in the Department of Neurosurgery, the Cancer Biology & Genetics Program and the Center for Stem Cell Biology, the …

Follow Memorial Sloan Kettering:    

Epic Sciences to Present Multiple Abstracts at ASCO 2020 Highlighting the Importance of CTCs in Liquid Biopsy | 5/26/2020

… data that shows the unique advantages of CTC single-cell genomic analysis in identifying alterations such as BRCA2 copy loss compared to tissue-based testing,” said Howard Scher, MD, Chief of Genitourinary Service at Memorial Sloan Kettering . /p p The data presented at this year’s ASCO Scientific Program complement the extensive ongoing clinical research in prostate cancer. Epic Sciences’ commercialized prostate cancer test for nuclear-localized AR-V7 assists physicians …

Hackensack Meridian Health Administers Treatment to 1,000th Patient in COVID-19 Clinical Trials | PR Newswire | 5/26/2020

… the first private medical school in New Jersey in more than 50 years, welcomed its first class of students in 2018 to its On3 campus in Nutley and Clifton . Additionally, the network partnered with Memorial Sloan Kettering Cancer Center to find more cures for cancer faster while ensuring that patients have access to the highest quality, most individualized cancer care when and where they need it. Hackensack Meridian Health is …

Cancer Stem Cells’ Reliance on a Key Amino Acid Could Be an Exploitable Weakness – On Cancer – Memorial Sloan Kettering | 5/26/2020

Cancer Stem Cells’ Reliance on a Key Amino Acid Could Be an Exploitable Weakness On Cancer – Memorial Sloan Kettering from “stem cells” – Google News https://ift.tt/2B4MqaT via IFTTT …

Patient Age, Use of Checkpoint Inhibitors in Cancer Linked to COVID-19 Severity | 5/26/2020

Cancer is among the underlying conditions that increase risk for COVID-19. A study by researchers from the Memorial Sloan Kettering Cancer Center estimated that 40% of the 423 patients with cancer who were symptomatic for SARS-CoV-2 were hospitalized for COVID-19. 1 Looking at these patients, the researchers identified several characteristics that conferred risk. A multivariable analysis showed that patients 65 years or older and those who …

‘I hit the trifecta’: She was battling cancer. Then came coronavirus and the complications. | Yahoo News | 5/26/2020

… cancer, requiring 12 rounds of chemotherapy and an 18-hour surgery to remove her ovaries, gallbladder, spleen, appendix and part of her colon. She relearned how to walk in the halls of New York’s Memorial Sloan Kettering Cancer Center. When she finished treatment and left, she hoped the cancer was gone and she would never have to come back. But a few months later, the disease returned, requiring chemotherapy that …

Cancer Stem Cells’ Reliance on a Key Amino Acid Could Be an Exploitable Weakness | Memorial Sloan Kettering Cancer Center | 5/26/2020

… Human Frontiers Science Program, the European Molecular Biology Organization, NYSTEM (CO29559), The Starr Foundation, the Damon Runyon Cancer Research Foundation, the Concern Foundation, the Anna Fuller Fund, The Edward Mallinckrodt, Jr. Foundation, and the Memorial Sloan Kettering Cancer Center Support Grant P30 CA008748. The study authors declare no competing interests. Related diseases …

Platinum Therapy May Up Survival in Pancreatic Cancer With DNA Repair Defects | 5/26/2020

For patients with advanced-stage pancreatic ductal adenocarcinoma (PDAC), those with homologous recombination deficiency (HRD) have improved survival with first-line (1L) platinum treatment, published online May 22 in Clinical Cancer Research . Wungki Park, M.D., from Memorial Sloan Kettering Cancer Center in New York City, and colleagues examined progression-free survival (PFS) and overall survival (OS) in advanced-stage PDAC. Homologous recombination gene mutations (HRm) were assessed in various genes …

Cancer hospitals like Memorial Sloan Kettering fight cancer and the coronavirus at the same time – NBC News | VOICE OF THE HWY | 5/26/2020

Cancer hospitals like Memorial Sloan Kettering fight cancer and the coronavirus at the same time – NBC News By Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. Headline Sports Follow us on Instagram @voiceofthehwy EDITOR PICKS MEDICAL NEWS 11 ABOUT US VOICE OF THE HIGHWAY (VOHWY …

Covid-19 study details benefits of treatment with remdesivir, and also its limitations | STAT | 5/23/2020

… the fact that the mortality result is not significant. He said he awaits results from future trials. Peter Bach, a pulmonologist who is the director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center, worried that it appears that slightly more placebo subjects started out in the more severe groups. This, he said, could mean that the overall effect is “potentially exaggerated.” “I am not …

Think twice before you take a salsa class (opinion) - CNN | 5/22/2020

Kent Sepkowitz is a CNN medical analyst and a physician and infection control expert at Memorial Sloan Kettering Cancer Center in New York. The views expressed in this commentary are his own. View more opinion at CNN. (CNN) South Korea’s aggressive testing and contact tracing program has given the country remarkable control of Covid-19, with the ability to respond quickly to new outbreaks. To top it off, South Korean …

Increasing concern about colorectal cancer risk in young adults | ExBulletin | 5/22/2020

… subtype of the disease is affecting young adults. Working to Questions also arise about the best ways to diagnose and treat CRC in this young population. Dr Zsofia K. Stadler, an oncologist at the Memorial Sloan Kettering Cancer Center in New York City and co-director of the annual Early-onset Colorectal Cancer Summit sponsored by the Patient Advocacy Organization, the Colorectal Cancer Foundation, sits at CURE®. I lowered it …

Platinum-based chemo may improve survival for some metastatic pancreatic cancer patients | 5/22/2020

… patients without these mutations. Journal in Which the Study was Published: Clinical Cancer Research , a journal of the American Association for Cancer Research Authors: The senior author was Eileen O’Reilly, MD, medical oncologist at Memorial Sloan Kettering Cancer Center (MSKCC). The lead author was Wungki Park, MD, medical oncologist at MSKCC. Background: Metastatic pancreatic cancer is associated with a challenging prognosis with a relative five-year survival rate of 2.9 …

[ASAP] An Azidoribose Probe to Track Ketoamine Adducts in Histone Ribose Glycation | 5/22/2020

An Azidoribose Probe to Track Ketoamine Adducts in Histone Ribose Glycation Igor Maksimovic Tri-Institutional PhD Program in Chemical Biology, New York, New York 10065, United States Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States Marissa N. Trujillo Marissa N. Trujillo James J. Galligan James J. Galligan Tri-Institutional PhD Program in Chemical Biology, New York, New York 10065, United States Chemical Biology …

Patients with Metastatic Pancreatic Cancer and DNA Repair Defects May Have Improved Survival after Platinum-based Chemotherapy | 5/22/2020

… current standard of care for metastatic pancreatic cancer includes platinum-based chemotherapy. “ Unfortunately, there are no validated biomarkers to predict which patients might benefit from standard treatment, ” said Eileen O’Reilly, MD , medical oncologist at Memorial Sloan Kettering Cancer Center (MSKCC) and senior author on the study. Biomarkers are biological features, such as DNA mutations, that can be used to predict prognosis or response to treatment. DNA mutations may be found …

Trial to assess hydroxychloroquine for COVID-19 prevention during cancer treatment | 5/22/2020

… may be at a higher risk for contracting COVID-19 during cancer treatment due to increased exposure,” Nancy Y. Lee, MD, FASTRO, vice chairman and radiation oncologist in the department of radiation oncology at Memorial Sloan Kettering Cancer Center, said in a press release. “There is an urgent need to identify effective risk-reduction strategies for these patients who require treatment for their cancer as we await effective therapeutic options …

EGFR Blockade Reverts Resistance to KRAS G12C Inhibition in Colorectal Cancer - PubMed | National Institutes of Health | 5/21/2020

doi: 10.1158/2159-8290.CD-20-0187. Online ahead of print. EGFR Blockade Reverts Resistance to KRAS G12C Inhibition in Colorectal Cancer 2 Department of Medicine, Memorial Sloan Kettering Cancer Center. 3 Dept of Oncology, University of Turin. 4 Candiolo Cancer Insititute-FPO, IRCCS. 5 Department of Oncology, University of Turin. 6 Oncology, Univeristy of Torino Medical School. 7 Candiolo Cancer Institute, FPO, IRCCS. 8 Candiolo Cancer Institute - FPO, IRCCS. 9 Memorial Sloan …

Why Florida can’t get its story straight on Covid numbers (opinion) - CNN | 5/21/2020

Kent Sepkowitz is a CNN medical analyst and a physician and infection control expert at Memorial Sloan Kettering Cancer Center in New York. The views View more opinion at CNN. (CNN) The Florida version of the Covid-19 pandemic continues to puzzle. Many had anticipated that the death rate there would be extremely high, given the state’s late and initially disorganized outbreak response and its elderly population. More than 4 …

Kids With Cancer Are Not at Greater Risk for COVID-10 | #covid19 | #kids | #childern | Parent Security Online | 5/21/2020

… latest findings that kids with cancer are not more endangered by COVID-19 and their symptoms are mild like in healthy children,” senior study author Andrew Kung, MD, PhD, chair of MSK Kids at Memorial Sloan Kettering Cancer Center in New York City said in a press release. “These findings allow us to continue lifesaving cancer-directed therapy with standard precautions and safeguards but without heightened concern about adverse effects …

AbbVie Announces 26 Nonprofits Selected for the COVID-19 Community Resilience Fund | PR Newswire | 5/21/2020

… Boston’s most vulnerable communities. Will use donation to enable effective screening procedures for patients and visitors, procuring and delivering PPE to health care workers and ramping up the facility’s capacity for telephonic health care. Memorial Sloan Kettering Cancer Center provides medical care as the world’s largest and oldest private cancer center. Will use donation for the Immigrant Health and Cancer Disparities Service in New York City , which connects vulnerable individuals …

New York Releases Guidelines for Hospital Visitation Pilot Program | Hamodia.com | 5/21/2020

… to allow hospital visitation, which had been mostly banned since March in an effort to limit transmission of the coronavirus. The initial announcement included 16 hospitals; four more have now been added, including the Memorial Sloan Kettering Cancer Center, Hospital for Special Surgery, Interfaith Medical Center and Richmond University Medical Center in Staten Island. Under the program, set to begin by next Tuesday, the day after Memorial Day, patients will …

COVID-19 Infection in Pediatric Patients With Cancer | 5/21/2020

5/21/2020 10:57:39 AM Advertisement In a study reported in a research letter in JAMA Oncology , Boulad et al found a low rate of COVID-19 morbidity among infected pediatric patients with cancer seen in the Memorial Sloan Kettering Cancer Center pediatric program, as well as a low rate of infection in patients without COVID-19 symptoms. The study was performed prior to identification of the multisystem inflammatory syndrome that has …

15 leadership changes affecting health IT this year | Becker’s Hospital Review | 5/20/2020

… as chief health information officer. Cedar, a patient payment and engagement platform, named Hassan Sultan as its chief technology officer. Indianapolis-based Indiana University Health appointed Tim Tarnowski as senior vice president and CIO. Memorial Sloan Kettering Cancer Center in New York City tapped Atefeh “Atti” Riazi as its CIO. Minneapolis-based Children’s Minnesota named Dave Lundal CIO and vice president of IT services. Johnson City, Tenn.-based Ballad Health …

Opioid-Related Deaths Less Likely Among Cancer Patients | 5/20/2020

… HealthDay News) — Opioid-related deaths in the cancer population are much rarer than in the general population, according to a research letter published online May 7 in JAMA Oncology . Fumiko Chino, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues used death certificate data from the National Center for Health Statistics (2006 to 2016) to assess opioids and cancer as underlying causes of deaths. The …

American Medical Association

10 physicians’ creative solutions for addressing hospital protective gear shortage | Becker’s Hospital Review | 3/24/2020

… proposed to address the personal protective equipment shortage during the COVID-19 pandemic. The editors of the Journal of the American Medical Association issued a call for ideas for conserving personal protective equipment, maximizing its … the help in our communities.” 2. John Healey, MD, of Memorial Sloan Kettering Cancer Center (New York City): “Personalized medicine for providers should be a priority, even while providing care in a pandemic. Well-fitting …

Clinical Research

Relmada Therapeutics Appoints CNS Specialist Thomas C. Wessel, M.D., Ph.D., as Executive Vice President, Head of Research and Development | PR Newswire | 3/9/2020

… served as Chief Medical Officer (CMO) for Acorda Therapeutics, Flex Pharma and more recently at Asceneuron. Dr. Wessel gained extensive experience in the development of CNS active isomers as Senior Vice President of Clinical Research at Sepracor. He also worked on several development projects in neurology and psychiatry at Janssen Pharmaceutical (Johnson & Johnson) in Europe and the United States . Dr. Wessel received his M.D. from the Ludwig-Maximilians-University in …

Gut Microbiome

The Parker Institute for Cancer Immunotherapy Awards $2.75 Million to Support Six Early Career Researchers from Leading Research Institutions | PR Newswire | 2/26/2020

… of immunotherapy experts. PICI selected the early career researchers from leading research institutions in its network, including City of Hope, Memorial Sloan Kettering Cancer Center, the Perelman School of Medicine at the University of Pennsylvania … tumors that are resistant to current immunotherapies, particularly with the gut microbiome. She will explore new immunotherapy combinations with CAR T-cell therapies to overcome resistance in current treatments for patients with brain cancer. Kelly …

Digital Health

Tech and health care need their own ‘Hippocratic oath’ - STAT | 12/23/2019

Tech and health care need their own ‘Hippocratic oath’ to make digital health work By Thomas M. Maddox and Simon MacGibbon December 23, 2019 Adobe W hen a whistleblower revealed the details of Project Nightingale … care have increasingly gravitated towards one another. Think IBM Watson , Memorial Sloan Kettering’s alliance with Paige.AI , and the fall of Outcome Health . These gaffes are exacerbating an already frayed trust between the public and the …

Food and Drug Administration

ENHERTU® Approved in the U.S. for HER2 Positive Unresectable or Metastatic Breast Cancer Following Two or More Prior Anti-HER2-Based Regimens | Business Wire | 12/21/2019

TOKYO & MUNICH & BASKING RIDGE, N.J.- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has approved ENHERTU ® (fam-trastuzumab deruxtecan-nxki), a HER2 directed antibody … limited treatment options,” said Shanu Modi, MD, Breast Medical Oncologist, Memorial Sloan Kettering Cancer Center. “ENHERTU has the potential to become a new standard of care.” The FDA approval is based on the results of …

National Cancer Institute

Kite Pharma, Juno duke it out in court over megamillion-dollar CAR-T patent | FiercePharma | 12/12/2019

Memorial Sloan Kettering Cancer Center in November 2013, the lawsuit claims. Before that license deal, back in 2007, a scientific collaborator with Kite named Steven Rosenberg posed some questions to Michel Sadelain, one of the inventors of the ‘190 patent, the suit says. Based on Rosenberg’s position as a National Cancer Institute researcher, Sadelain referred his fellow scientist to a 2002 journal article that discussed the patent, the lawsuit suit …

Biotech

EMBARGOED-Eli Lilly to put Loxo executives in charge of new cancer research unit | Yahoo News | 12/5/2019

… will create a new cancer research division that will be run by top executives from Loxo Oncology, a cancer-focused biotech company it acquired earlier this year.” data-reactid=”13” Dec 5 (Reuters) - U.S. drugmaker … serves as chief of the early drug development service at Memorial Sloan Kettering Cancer Center in New York. They will report to Daniel Skovronsky, Lilly’s chief scientific officer. “We intend to create a balanced pipeline …

National Institutes of Health

Global Proteomics Partnering Terms and Agreements 2014-2019 - Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indication | The Wapakoneta Daily News | 12/4/2019

… Epicypher Epivax Eucodis Bioscience Eureka Eurostars Eurobio European Bioinformatics Institute Evogen Evosep Exactis Innovation Fluidigm FORMA Therapeutics Foundation for the National Institutes of Health (FNIH) Fred Hutchinson Cancer Research Center French National Research Agency Gallus … Anderson Cancer Center Medgenics Medical University of South Carolina MedImmune Memorial Sloan Kettering Cancer Center Merck and Co Metabolon Moderna Therapeutics Mologic MRM Proteomics Munich Technical University NanoString Technologies NantBioScience NantHealth National Heart Lung and …

Credentialing

Hackensack Meridian Health Invests in Adaptive Phage Therapeutics, Aiming to Kill ‘Superbugs’ as Part of Bear’s Den Innovation Program | PR Newswire | 12/4/2019

Credentialing Center and being named to Becker’s Healthcare’s “150 Top Places to Work in Healthcare/2019” list. The Hackensack Meridian School of Medicine at Seton Hall University , the first private medical school in New Jersey in more than 50 years, welcomed its first class of students in 2018 to its On3 campus in Nutley and Clifton . Additionally, the network partnered with Memorial Sloan Kettering Cancer Center to find more cures …

Ohio State University

Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine | PR Newswire | 12/4/2019

… to impact surgical decisions and chemotherapy,” explained Robert Pilarski , MS, LGC; MSW, Licensed Genetic Counselor, Professor, Clinical Internal Medicine, The Ohio State University Comprehensive Cancer Center , Vice-Chair of the NCCN Guidelines Panel for Genetic … Cancer Center, Phoenix / Scottsdale, AZ , Jacksonville, FL , and Rochester, MN ; Memorial Sloan Kettering Cancer Center, New York, NY ; Moffitt Cancer Center, Tampa, FL ; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove …

CRISPR

Global Proteomics Partnering Terms and Agreements 2014-2019 - Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indication | The Wapakoneta Daily News | 12/4/2019

… County Children’s Medical Research Institute Children’s Hospital Colorado Chugai Pharmaceutical Cisbio Bioassays Codexis Core Diagnostics India COTA CPR Pharma Services CRISPR Therapeutics Cyclenium Pharma Datavant Delphi Genetics Dimerix Biosciences Dnastar DuPont Industrial Biosciences Dyadic International … Anderson Cancer Center Medgenics Medical University of South Carolina MedImmune Memorial Sloan Kettering Cancer Center Merck and Co Metabolon Moderna Therapeutics Mologic MRM Proteomics Munich Technical University NanoString Technologies NantBioScience NantHealth National Heart Lung and …

Medical Research

Hackensack Meridian Health Invests in Adaptive Phage Therapeutics, Aiming to Kill ‘Superbugs’ as Part of Bear’s Den Innovation Program | PR Newswire | 12/4/2019

… first private medical school in New Jersey in more than 50 years, welcomed its first class of students in 2018 to its On3 campus in Nutley and Clifton . Additionally, the network partnered with Memorial Sloan Kettering Cancer Center to find more cures for cancer faster while ensuring that patients have access to the highest quality, most individualized cancer care when and where they need it. Hackensack Meridian Health is a …

Smoking Cessation

Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine | PR Newswire | 12/4/2019

… percent of cancers affecting patients in the United States , there are also NCCN Guidelines for detection, prevention, risk-reduction (including smoking cessation ), supportive care (including the management of pain , distress , and fatigue ), and guidelines for … Cancer Center, Phoenix / Scottsdale, AZ , Jacksonville, FL , and Rochester, MN ; Memorial Sloan Kettering Cancer Center, New York, NY ; Moffitt Cancer Center, Tampa, FL ; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove …

Feinberg School of Medicine

Retrospective Analysis Identifies Need for Better Classification of Rare Lymphoma | 12/4/2019

Memorial Sloan Kettering Cancer Center; Joan Guitart, MD, and Maria Estela Martinez-Escala, MD, both Northwestern University Feinberg School of Medicine; Sharmir Geller, MD and Yaqun Wang, both Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; N. Nora Bennani, MD and Kay M. Ristow, BS, both Mayo Clinic; Daniel J. Landsburg, MD Abramson Cancer Center; Nicole Winchell and Paul Haun, MD, both University of Pennsylvania; Pamela Allen, MD, MSc, Emory …

The Ohio State University

Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine | PR Newswire | 12/4/2019

… potential to impact surgical decisions and chemotherapy,” explained Robert Pilarski , MS, LGC; MSW, Licensed Genetic Counselor, Professor, Clinical Internal Medicine, The Ohio State University Comprehensive Cancer Center , Vice-Chair of the NCCN Guidelines Panel for … Cancer Center, Phoenix / Scottsdale, AZ , Jacksonville, FL , and Rochester, MN ; Memorial Sloan Kettering Cancer Center, New York, NY ; Moffitt Cancer Center, Tampa, FL ; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove …

University of Tennessee

Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine | PR Newswire | 12/4/2019

Memorial Sloan Kettering Cancer Center, New York, NY ; Moffitt Cancer Center, Tampa, FL ; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH ; O’Neal Comprehensive Cancer Center at UAB, Birmingham, AL ; Roswell Park Comprehensive Cancer Center, Buffalo, NY ; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO ; St. Jude Children’s Research Hospital/The University of Tennessee Health …

Pain Management

SPR Therapeutics Announces 1000th Sprint PNS Procedure | Globe Newswire | 12/4/2019

… shoulder pain. SPR Therapeutics, Inc. CLEVELAND, Dec. 04, 2019 (GLOBE NEWSWIRE) – SPR Therapeutics, Inc. , a leader in neurostimulation technology for pain management, announced today the successful commercial placement of its 1000 th SPRINT Peripheral Nerve … and Nerve Centers of the Virginias, MossRehab, Shepherd Center and Memorial Sloan Kettering Cancer Center. The system is now available in over 20 major U.S. cities. SPRcare offers a reimbursement support service to help patients …

Home Health

Hackensack Meridian Health Invests in Adaptive Phage Therapeutics, Aiming to Kill ‘Superbugs’ as Part of Bear’s Den Innovation Program | PR Newswire | 12/4/2019

… Additionally, the network has more than 500 patient care locations throughout the state which include ambulatory care centers, surgery centers, home health services, long-term care and assisted living communities, ambulance services, lifesaving air medical … campus in Nutley and Clifton . Additionally, the network partnered with Memorial Sloan Kettering Cancer Center to find more cures for cancer faster while ensuring that patients have access to the highest quality, most individualized cancer …

Behavioral Health

Hackensack Meridian Health Invests in Adaptive Phage Therapeutics, Aiming to Kill ‘Superbugs’ as Part of Bear’s Den Innovation Program | PR Newswire | 12/4/2019

… Bay Medical Center in Perth Amboy , Riverview Medical Center in Red Bank , and Southern Ocean Medical Center in Manahawkin ; a behavioral health hospital – Carrier Clinic in Belle Mead ; and two rehabilitation hospitals – JFK Johnson Rehabilitation … campus in Nutley and Clifton . Additionally, the network partnered with Memorial Sloan Kettering Cancer Center to find more cures for cancer faster while ensuring that patients have access to the highest quality, most individualized cancer …

Medical Transportation

Hackensack Meridian Health Invests in Adaptive Phage Therapeutics, Aiming to Kill ‘Superbugs’ as Part of Bear’s Den Innovation Program | PR Newswire | 12/4/2019

… include ambulatory care centers, surgery centers, home health services, long-term care and assisted living communities, ambulance services, lifesaving air medical transportation, fitness and wellness centers, rehabilitation centers, urgent care centers and physician practice locations … campus in Nutley and Clifton . Additionally, the network partnered with Memorial Sloan Kettering Cancer Center to find more cures for cancer faster while ensuring that patients have access to the highest quality, most individualized cancer …

Integrative Medicine

Asia’s 2019 Heroes Of Philanthropy: Catalysts For Change | Forbes | 12/3/2019

… of Complementary Medicine at Western Sydney University and a A$1.3 million donation in 2015 to establish a chair in integrative medicine at the University of Sydney. Blackmore owns a 23% stake in the Blackmores … oncology. The couple also pledged $2 million recently to the Memorial Sloan Kettering Cancer Center in New York to establish the Mazumdar-Shaw International Clinical Fellowships. Mazumdar-Shaw, who signed the Giving Pledge in 2016 …

American College of Radiology

American College of Radiology, Breast Cancer Research Foundation and GE Healthcare Announce a Planned Trial to Evaluate Use of Contrast Enhanced Mammography for Screening Women with Dense Breasts | PR Newswire | 12/2/2019

American College of Radiology, Breast Cancer Research Foundation and GE Healthcare Announce a Planned Trial to Evaluate Use of Contrast Enhanced Mammography for Screening Women with Dense Breasts News provided by Dec 02, 2019, 07:30 … Comstock , MD, FACR, FSBI, director of breast imaging clinical trials, Memorial Sloan Kettering Cancer Center. “We know that one size does not fit all when it comes to breast care, and that it’s critical to …

Patient Safety

Depression in doctors linked to increase in medical errors, study finds | Healthcare Dive | 12/2/2019

… Researchers from the University of Michigan School of Medicine, Federal University of So Paulo, the University of Sao Paulo and Memorial Sloan Kettering Cancer Center undertook a survey of prior studies linking medical errors to … in the future, noting “physician well-being is critical to patient safety.” “Given that few physicians with depression seek treatment and that recent evidence has pointed to the lack of organizational interventions aimed at reducing …

Big Pharma

The Cancer Within Modern Medicine Part 1 & 2: Explosive | 12/2/2019

… century to present day, increased consolidation of drug companies has led to the emergence of what we know of as big pharma. With billions in profits, the big pharma lobby has influenced lawmakers and policy … J.D. Rockefeller and John Edward Parsons, the first president of Memorial Sloan Kettering Cancer Center, which was built on land donated by Rockefeller. A group of wealthy women were also on the ground floor of …

Gene Therapy

American College of Radiology, Breast Cancer Research Foundation and GE Healthcare Announce a Planned Trial to Evaluate Use of Contrast Enhanced Mammography for Screening Women with Dense Breasts | PR Newswire | 12/2/2019

… for women with dense breasts,” said CMIST Principal Investigator Christopher Comstock , MD, FACR, FSBI, director of breast imaging clinical trials, Memorial Sloan Kettering Cancer Center. “We know that one size does not fit all when … leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years …

Bristol-Myers Squibb

Bristol-Myers Squibb | 4/5/2020

Support for the American Legislative Exchange Council Bristol-Myers Squibb is a corporate member of the American Legislative Exchange Council (ALEC) as of 2009. [3] About ALEC ALEC is a corporate bill mill. It is not just a lobby or a front group; it is much more powerful than that. Through ALEC, corporations hand state legislators their wishlists to benefit their bottom line. Corporations fund almost all of ALEC’s operations …

Johnson & Johnson

Relmada Therapeutics Appoints CNS Specialist Thomas C. Wessel, M.D., Ph.D., as Executive Vice President, Head of Research and Development | PR Newswire | 3/9/2020

… gained extensive experience in the development of CNS active isomers as Senior Vice President of Clinical Research at Sepracor. He also worked on several development projects in neurology and psychiatry at Janssen Pharmaceutical (Johnson & Johnson) in Europe and the United States . Dr. Wessel received his M.D. from the Ludwig-Maximilians-University in Munich, Germany , and his Ph.D. in experimental neurobiology at the Max-Planck-Institute for Psychiatry in Martinsried, Germany …

Seattle Genetics

Seattle Genetics and Astellas Announce Updated Results from Phase 1b/2 Trial of PADCEV™ (enfortumab vedotin-ejfv) in Combination with Immune Therapy Pembrolizumab as Investigational First-Line Treatment for Advanced Bladder Cancer | PR Newswire | 2/11/2020

Sverige Seattle Genetics and Astellas Announce Updated Results from Phase 1b/2 Trial of PADCEV™ (enfortumab vedotin-ejfv) in Combination with Immune Therapy Pembrolizumab as Investigational First-Line Treatment for Advanced Bladder Cancer - After Median … M.D., Medical Oncologist and Chief, Genitourinary Medical Oncology Service at Memorial Sloan Kettering Cancer Center in New York. “I’m encouraged by these interim results, including a median progression-free survival of a year for patients …

Cerner

16 hospitals, health systems seeking Allscripts, Cerner, Epic, Meditech talent | Becker’s Hospital Review | 1/29/2020

Four of the top vendors hospitals use to participate in the Medicare EHR Incentive Program are Allscripts, Cerner, Epic and Meditech, according to 2018 ONC data . Sixteen hospitals and health systems that posted job listings seeking EHR and IT expertise during the past two weeks: Editor’s note: This is not an exhaustive list. Job listings were compiled from job seeker websites. Allscripts 1. Memorial Sloan Kettering (New York City): Seeks …

Gilead

CAR-T patent damages at $1.5B? BMS urges court to hike $752M award against Gilead - FiercePharma (0 visits) | 1/23/2020

CAR-T patent damages at $1.5B? BMS urges court to hike $752M award against Gilead by Jan 23, 2020 11:15am Bristol-Myers owns Juno Therapeutics after its buyout last year of Celgene. (BMS) In a … Therapeutics had licensed from researchers at Sloan Kettering and the Memorial Sloan Kettering Cancer Center. The jury ordered Kite, now part of Gilead, to pay $752 million in damages. That number was calculated based on …

Eli Lilly

HSS moves closer to kicking off $300M River Building project | Crain’s New York Business | 1/21/2020

… judges “do not deprecate” the view of the co-op building that factors such as development in the area by Memorial Sloan Kettering, Weill Cornell Medicine and HSS should have been considered, the planning commission … H for its life sciences campus, where Bristol-Myers Squibb, Eli Lilly, Pfizer and NYU Langone rent space. VAPING DEATHS: The state Department of Health has confirmed two more deaths in New York from vaping …

AstraZeneca

The 10 Shkreli Award recipients that exemplified ‘profiteering and dysfunction’ in healthcare | Becker’s Hospital Review | 1/9/2020

Memorial Sloan Kettering Cancer Center. Dr. Baselga resigned from the medical center after failing to disclose millions of dollars in payments from drug companies. After his resignation, he was tapped to lead AstraZeneca’s new oncology research unit. 9. Newark (N.J.) Beth Israel Medical Center and Mark Zucker, MD, the hospital’s heart and lung transplant program director. The hospital is accused of keeping a vegetative patient alive for a year to …

Bristol-Myers

Kite Pharma ordered to pay Juno Therapeutics $752M in CAR-T drug infringement case | Becker’s Hospital Review | 12/16/2019

A federal jury Dec. 13 ordered Gilead Sciences subsidiary Kite Pharma to pay $752 million to Bristol-Myers Squibb subsidiary Juno Therapeutics for allegedly violating a patent when developing its CAR-T drug, Yescarta, according to MedCity News . In 2017, Kite received approval for Yescarta, designed to treat lymphoma. Juno then sued Kite, alleging it used research patented by Memorial Sloan Kettering Cancer Center and licensed by Juno to develop …

Novartis

Kite Pharma, Juno duke it out in court over megamillion-dollar CAR-T patent | FiercePharma | 12/12/2019

… technology invented and patented by scientists at Sloan Kettering. Juno exclusively licensed the ‘190 patent from Sloan Kettering and the Memorial Sloan Kettering Cancer Center in November 2013, the lawsuit claims. Before that license deal … didn’t immediately respond to requests for comment. RELATED: Move over, Novartis: Kite and Gilead break into CAR-T market with early axi-cel nod Further, Kite tried to challenge the ‘190 patent with an inter …

Celgene

Global Proteomics Partnering Terms and Agreements 2014-2019 - Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indication | The Wapakoneta Daily News | 12/4/2019

… Cambridge Isotope Laboratories Cambridge Research Biochemicals Camino Partnership Caprion Biosciences Caprion Proteomics Caris Life Sciences Casebia Therapeutics Catabasis Pharmaceuticals Celares Celgene Celsee Center for Human Immunology Autoimmunity and Inflammation Centogene Centre For Proteomic & Genomic Research … Anderson Cancer Center Medgenics Medical University of South Carolina MedImmune Memorial Sloan Kettering Cancer Center Merck and Co Metabolon Moderna Therapeutics Mologic MRM Proteomics Munich Technical University NanoString Technologies NantBioScience NantHealth National Heart Lung and …

AbbVie

Global Proteomics Partnering Terms and Agreements 2014-2019 - Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indication | The Wapakoneta Daily News | 12/4/2019

… 4 - Proteomics deals by therapy area Appendix 5 -Deal type definitions Companies Mentioned 3SBio A STAR Bioinformatics Institute AB Analitica Abbvie Ablynx Absorption Systems Advaita Advanced Manufacturing Fund Aelan Cell Technologies Affibody Albumedix Alexion Pharmaceuticals … Anderson Cancer Center Medgenics Medical University of South Carolina MedImmune Memorial Sloan Kettering Cancer Center Merck and Co Metabolon Moderna Therapeutics Mologic MRM Proteomics Munich Technical University NanoString Technologies NantBioScience NantHealth National Heart Lung and …

Boehringer Ingelheim

Global Proteomics Partnering Terms and Agreements 2014-2019 - Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indication | The Wapakoneta Daily News | 12/4/2019

… South Dakota Axil Scientific Bayer Bellus Health Berg Bio-Techne Biocartis Biodesix Biognosys BioNova Cientifica Biotest bioVidria Bioyong BluePen Biomarkers Boehringer Ingelheim Bristol-Myers Squibb Bruker c-LEcta California Institute for Quantitative Biosciences (QB3) Cambridge … Anderson Cancer Center Medgenics Medical University of South Carolina MedImmune Memorial Sloan Kettering Cancer Center Merck and Co Metabolon Moderna Therapeutics Mologic MRM Proteomics Munich Technical University NanoString Technologies NantBioScience NantHealth National Heart Lung and …

Thermo Fisher

Global Proteomics Partnering Terms and Agreements 2014-2019 - Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indication | The Wapakoneta Daily News | 12/4/2019

… Luxembourg Institute of Health Mariel Therapeutics Massachusetts General Hospital MD Anderson Cancer Center Medgenics Medical University of South Carolina MedImmune Memorial Sloan Kettering Cancer Center Merck and Co Metabolon Moderna Therapeutics Mologic MRM Proteomics Munich … Tetragenetics The Hospital for Sick Children Theranostics Health Therapure Biopharma Thermo Fisher Scientific TME Research Transgenomic Translational Drug Development UCB University of British Columbia University of California San Francisco University of Florida University of Greifswald …

Purdue Pharma

Global Proteomics Partnering Terms and Agreements 2014-2019 - Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indication | The Wapakoneta Daily News | 12/4/2019

… Luxembourg Institute of Health Mariel Therapeutics Massachusetts General Hospital MD Anderson Cancer Center Medgenics Medical University of South Carolina MedImmune Memorial Sloan Kettering Cancer Center Merck and Co Metabolon Moderna Therapeutics Mologic MRM Proteomics Munich … Bioscience Pressure BioSciences Probiodrug AG Pronutria Proteomics International Prothelia pSivida Purdue Pharma Purdue Research Foundation Purolite Reaction Biology Replicel Life Sciences rEVO Biologics Roche Saint Louis University Saromics Scienion Sciex Scripps Research Institute Selecta Biosciences …

GE Healthcare

American College of Radiology, Breast Cancer Research Foundation and GE Healthcare Announce a Planned Trial to Evaluate Use of Contrast Enhanced Mammography for Screening Women with Dense Breasts | PR Newswire | 12/2/2019

American College of Radiology, Breast Cancer Research Foundation and GE Healthcare Announce a Planned Trial to Evaluate Use of Contrast Enhanced Mammography for Screening Women with Dense Breasts News provided by Dec 02, 2019, 07:30 … Comstock , MD, FACR, FSBI, director of breast imaging clinical trials, Memorial Sloan Kettering Cancer Center. “We know that one size does not fit all when it comes to breast care, and that it’s critical to …

Weill Cornell Medicine

Is Traditional Chinese Medicine Use Associated with Worse Patient-reported Outcomes among Chinese American Rheumatology Patients? | 12/1/2019

Memorial Sloan Kettering Cancer Center; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery; Department of Medicine, Weill Cornell Medicine, New York, New York, USA . Previous Next Abstract Objective. Chinese Americans are a fast-growing immigrant group with more severe rheumatic disease manifestations than whites and often a strong cultural preference for traditional Chinese medicine (TCM). We aimed to examine TCM use patterns and association with patient-reported outcomes …

Gilead Sciences

Milking It: Study in Mice Suggests Lactose in the Diet Feeds Dangerous Gut Bacteria | Memorial Sloan Kettering Cancer Center | 11/29/2019

… which immune cells from the donor’s stem cells attack the recipient’s organs. Now, an international team led by scientists from Memorial Sloan Kettering has shown for the first time that foods containing lactose, a sugar … Science and Technology, a Conquer Cancer Foundation Young Investigator Award/Gilead Sciences, and more than a dozen National Institutes of Health grants (R01-CA228358, R01-CA228308, P30 CA008748, P01-CA023766, R01-HL125571, R01-HL123340, P01 …

Amgen

Milking It: Study in Mice Suggests Lactose in the Diet Feeds Dangerous Gut Bacteria | Memorial Sloan Kettering Cancer Center | 11/29/2019

… which immune cells from the donor’s stem cells attack the recipient’s organs. Now, an international team led by scientists from Memorial Sloan Kettering has shown for the first time that foods containing lactose, a sugar … for Seres Therapeutics, Flagship Ventures, Novartis, Evelo, Jazz Pharmaceuticals, Therakos, Amgen, Magenta Therapeutics, WindMIL Therapeutics, Merck & Co. Inc., Acute Leukemia Forum (ALF), and DKMS Medical Council (Board). He also has IP licensing with Seres Therapeutics …

Biogen

Genome Editing Services, World Markets to 2030: Focus on CRISPR - The Most Popular Genome Manipulation Technology Tool | The Wapakoneta Daily News | 11/28/2019

… Portfolio 6.2.3. Recent Developments and Future Outlook 6.3. BioCat 6.4. Biotools 6.5. Charles River Laboratories 6.6. Cobo Scientific 6.7. Creative Biogene 6.8. Cyagen Biosciences 6.9. GeneCopoeia 6.10. Horizon Discovery 6.11. NemaMetrix 6.12. Synbio Technologies 6.13 … Center Medical College of Wisconsin Medigene MedImmune Medisix Therapeutics MeiraGTx Memorial Sloan Kettering Cancer Center Merck Mesoblast Microsynth Mie University Hospital Milo Biotechnology Miltenyi Biotec Minerva Biotechnologies MingJu Therapeutics Mirimus Moffitt Cancer Center MolMed Momotaro …

Genentech

Genome Editing Services, World Markets to 2030: Focus on CRISPR - The Most Popular Genome Manipulation Technology Tool | The Wapakoneta Daily News | 11/28/2019

… University Fujita Health University Fulcrum Therapeutics Gadeta GEG Tech Gemini Therapeutics Genable Technologies GenAhead Bio GeneCopoeia GeneCure Biotechnologies GenEdit Genelux Genentech GeneOne Life Science GenePharma GeneQuine Biotherapeutics Generation Bio Genethon Genetics Research GENEWIZ Genexine Genmab … Center Medical College of Wisconsin Medigene MedImmune Medisix Therapeutics MeiraGTx Memorial Sloan Kettering Cancer Center Merck Mesoblast Microsynth Mie University Hospital Milo Biotechnology Miltenyi Biotec Minerva Biotechnologies MingJu Therapeutics Mirimus Moffitt Cancer Center MolMed Momotaro …

Regeneron Pharmaceuticals

Genome Editing Services, World Markets to 2030: Focus on CRISPR - The Most Popular Genome Manipulation Technology Tool | The Wapakoneta Daily News | 11/28/2019

… Massachusetts Institute of Technology MaxCyte Mayo Clinic MD Anderson Cancer Center Medical College of Wisconsin Medigene MedImmune Medisix Therapeutics MeiraGTx Memorial Sloan Kettering Cancer Center Merck Mesoblast Microsynth Mie University Hospital Milo Biotechnology Miltenyi Biotec … Therapeutics Purdue University Qingdao Central Hospital Quethera Recombinetics Refuge Biotechnologies Regeneron Pharmaceuticals REGENXBIO RenJi Hospital Renova Therapeutics Rentschler Biopharma Repare Therapeutics ReproCELL RetroSense Therapeutics Reyon Pharmaceutical Roche Rocket Pharmaceuticals Rockland Immunochemicals Roger Williams Medical Center …

Spark Therapeutics

Genome Editing Services, World Markets to 2030: Focus on CRISPR - The Most Popular Genome Manipulation Technology Tool | The Wapakoneta Daily News | 11/28/2019

… Massachusetts Institute of Technology MaxCyte Mayo Clinic MD Anderson Cancer Center Medical College of Wisconsin Medigene MedImmune Medisix Therapeutics MeiraGTx Memorial Sloan Kettering Cancer Center Merck Mesoblast Microsynth Mie University Hospital Milo Biotechnology Miltenyi Biotec … Southern Medical University Southwest Hospital Spanish National Centre for Biotechnology Spark Therapeutics Spindle Biotech SR-TIGET St. Jude Children’s Research Hospital Stanford University STEMCELL Technologies Stony Brook University StrideBio Sun Yat-Sen Memorial Hospital of …

MedImmune

Genome Editing Services, World Markets to 2030: Focus on CRISPR - The Most Popular Genome Manipulation Technology Tool | The Wapakoneta Daily News | 11/28/2019

MedImmune Medisix Therapeutics MeiraGTx Memorial Sloan Kettering Cancer Center Merck Mesoblast Microsynth Mie University Hospital Milo Biotechnology Miltenyi Biotec Minerva Biotechnologies MingJu Therapeutics Mirimus Moffitt Cancer Center MolMed Momotaro-Gene Monsanto MultiVir Mustang Bio Myonexus Therapeutics Nagoya University Nanfang Hospital of Southern Medical University Nanjing Children’s Hospital Nanjing Legend Biotech NanoCor Therapeutics Nanogenics Nanosens Innovations National Cancer Institute National Eye Institute National Heart, Lung, and Blood Institute National Human Genome …

Allergan

Genome Editing Services, World Markets to 2030: Focus on CRISPR - The Most Popular Genome Manipulation Technology Tool | The Wapakoneta Daily News | 11/28/2019

… Research (A STAR) AgenTus Therapeutics Agilent Technologies Agilis Biotherapeutics Akouos Albert Einstein College of Medicine Aldevron Alex’s Lemonade Stand Foundation Allergan Allife Medical Science and Technology Allogene Therapeutics AlphaVax ALSTEM Altor Bioscience American Gene Technologies … Center Medical College of Wisconsin Medigene MedImmune Medisix Therapeutics MeiraGTx Memorial Sloan Kettering Cancer Center Merck Mesoblast Microsynth Mie University Hospital Milo Biotechnology Miltenyi Biotec Minerva Biotechnologies MingJu Therapeutics Mirimus Moffitt Cancer Center MolMed Momotaro …

Healthgrades

Hackensack Meridian Health Ocean Medical Center Reveals Plans for Heart and Vascular Center | 11/27/2019

… 2019, Ocean Medical Center was once again awarded an ‘A’ rating in the Leapfrog Safety Grade and received the 2019 Healthgrades Patient Safety Excellence Award for superior safety performance. Ocean Medical Center received the highest … campus in Nutley and Clifton. Additionally, the network partnered with Memorial Sloan Kettering Cancer Center to find more cures for cancer faster while ensuring that patients have access to the highest quality, most individualized cancer …

Goldman Sachs

Former Goldman Sachs CIO joins Memorial Sloan Kettering spinoff: 4 things to know | Becker’s Hospital Review | 1/10/2020

R. Martin Chavez, PhD, a former Goldman Sachs executive who left the investment bank at the end of 2019, has joined the board of directors of Paige, a startup developing artificial intelligence for cancer diagnosis … round, was founded by researchers at New York City-based Memorial Sloan Kettering Cancer Center. The startup’s platform offers AI-driven diagnostics for more accurate and lower-cost cancer diagnosis and treatment. 4. At Paige …

Breyer Capital

AI-enabled oncology platform Paige lands $45M | MobiHealthNews | 12/18/2019

Health Venture Partners led the round with participation from Breyer Capital, Kenan Turnacioglu and other funders. December 18, 2019 Share This morning the AI-enabled diagnostic and treatment platform Paige, formerly called Paige.AI, announced a … reducible algorithms. Founded in 2018, the company was born at Memorial Sloan Kettering. Currently the medical center has intellectual property rights and interests in the company. In March the company was granted a Breakthrough Device …

NCI

Merus charts early promise for cancer drug targeting NRG1 fusions | FierceBiotech | 10/28/2019

Memorial Sloan Kettering Cancer Center at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. Take the Survey Zenocutuzumab was designed to work in two different ways: One part of the drug blocks the interaction between the cancer-driving proteins HER2 and HER3. Another arm of the drug blocks NRG1 fusions so they can’t activate HER3. One patient with pancreatic cancer who received zenocutuzumab saw …

Khosla Ventures

‘It’s a little ‘Star Trekky’’: How this S.F. startup looks to create 3D-printed organs | The Business Journals | 8/23/2019

… plans to move to Hayward, has found a way: The company landed an $8.7 million Series A round led by Khosla Ventures and including True Ventures and SOSV’s IndieBio. What’s more, Prellis appears to going … scientists at the University of California, San Francisco, Johns Hopkins, Memorial Sloan Kettering and other research centers to reduce the time it takes to screen drugs. Matheu expects to use the tissue in humans in …

Versant Ventures

Bayer AG buys BlueRock Therapeutics for $1 bln | PE Hub | 8/8/2019

Bayer AG buys BlueRock Therapeutics for $1 bln August 8, 2019 Bayer AG has acquired BlueRock Therapeutics from Versant Ventures for up to $1 billion. BlueRock, a biotech, focuses on stem cell research. PRESS RELEASE … Health Network in Toronto and the Stem Cell Center at Memorial Sloan Kettering in New York, key management talent, intellectual property, as well as manufacturing expertise from partners. In December 2016, BlueRock came out of …

Daiichi Sankyo

FDA Approves Daiichi Sankyo’s TURALIO™ (pexidartinib) for the Treatment of Select Patients with TGCT, a Rare and Debilitating Tumor | Markets Insider | Business Insider | 8/5/2019

… of the tendon sheath (GCT-TS), can be locally aggressive and debilitating - To mitigate the risk of serious liver injury, Daiichi Sankyo proactively developed a Risk Evaluation and Mitigation Strategy (REMS) Program and patient registry … Tap, MD, Chief of the Sarcoma Medical Oncology Service at Memorial Sloan Kettering Cancer Center, New York , and lead investigator for the pivotal phase 3 ENLIVEN study. “We now have a new oral treatment option …

Leukemia & Lymphoma Society

Risk of disease progression in low-risk MDS is linked to distinct epigenetic subtypes | Nature | 7/22/2019

… Doris Duke Foundation (2011044) and an NIH NHLBI R01HL126947 to MEF. MEF, RLL and SDN were also supported by a Leukemia & Lymphoma Society SCOR award (7071-18). The authors would like to acknowledge the support of … MI, 48109, USA Jason Sotzen Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA Raajit K. Rampal Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York …

Battery Ventures

How Redox Is Transforming The Way Healthcare Providers Share Data | 4/28/2019

… way healthcare providers and software vendors share data, announced it has raised $33 million in Series C funding led by Battery Ventures. Also participating in this round is .406 Ventures, RRE Ventures, and Intermountain Ventures … Health, Cleveland Clinic, Geisinger, HCA, Healthgrades, Intermountain Healthcare, Invitae, Fitbit, Memorial Sloan Kettering, Microsoft, Ochsner, OSF HealthCare, PointClickCare, R1, ResMed, Stryker, UCSF, University of Pennsylvania, and WellStar. “Redox is a driving force in solving healthcare’s …

RRE Ventures

How Redox Is Transforming The Way Healthcare Providers Share Data | 4/28/2019

… has raised $33 million in Series C funding led by Battery Ventures. Also participating in this round is .406 Ventures, RRE Ventures, and Intermountain Ventures. In conjunction with this funding round, Battery general partner Chelsea … Health, Cleveland Clinic, Geisinger, HCA, Healthgrades, Intermountain Healthcare, Invitae, Fitbit, Memorial Sloan Kettering, Microsoft, Ochsner, OSF HealthCare, PointClickCare, R1, ResMed, Stryker, UCSF, University of Pennsylvania, and WellStar. “Redox is a driving force in solving healthcare’s …

Stryker

How Redox Is Transforming The Way Healthcare Providers Share Data | 4/28/2019

… Memorial Sloan Kettering, Microsoft, Ochsner, OSF HealthCare, PointClickCare, R1, ResMed, Stryker, UCSF, University of Pennsylvania, and WellStar. “Redox is a driving force in solving healthcare’s interoperability challenge,” added Stoner. “We were blown away by the network effects Redox has already generated and how foundational its platform has become to achieving the promise of digital health. Given its top-notch leadership team and the important problem it is solving, there was …

406 Ventures

Redox raises $33M in Series C Funding Led by Battery Ventures to Revolutionize How Healthcare Data Is Exchanged | 4/22/2019

… closed a $33 million Series C funding round led by global investment firm Battery Ventures with participation from existing investors .406 Ventures, RRE Ventures, and Intermountain Ventures. As part of the transaction, Battery General Partner … Health, Cleveland Clinic, Geisinger, HCA, Healthgrades, Intermountain Healthcare, Invitae, Fitbit, Memorial Sloan Kettering, Microsoft, Ochsner, OSF HealthCare , PointClickCare , R1, ResMed, Stryker, UCSF, University of Pennsylvania, and WellStar. In addition to its numerous customer wins and …

Spring Mountain Capital

UCLA and Caltech Study Uses Technology Being Commercialized by IsoPlexis To Characterize Cancer | PR Newswire | 12/14/2017

Memorial Sloan Kettering Cancer Center have advanced understandings of personalized therapies against various cancers. IsoPlexis is venture funded by Spring Mountain Capital, North Sound Ventures, and Connecticut Innovations, as well as supported through grant funding from the National Cancer Institute and the National Institutes of Health. For additional information on IsoPlexis, visit http://www.isoplexis.com or email [email protected] . View original content with multimedia: http://www.prnewswire.com/news-releases/ucla-and-caltech …

Sound Ventures

UCLA and Caltech Study Uses Technology Being Commercialized by IsoPlexis To Characterize Cancer | PR Newswire | 12/14/2017

Memorial Sloan Kettering Cancer Center have advanced understandings of personalized therapies against various cancers. IsoPlexis is venture funded by Spring Mountain Capital, North Sound Ventures, and Connecticut Innovations, as well as supported through grant funding from the National Cancer Institute and the National Institutes of Health. For additional information on IsoPlexis, visit http://www.isoplexis.com or email [email protected] . View original content with multimedia: http://www.prnewswire.com/news-releases/ucla-and-caltech …

Star Mountain Capital

Star Mountain Capital is the #1 Fundraising Team for the Terry Fox Run for Cancer Research (New York City) for the Second Year in a Row | 10/18/2017

googlecse  Star Mountain Capital is the 1 Fundraising Team for the Terry Fox Run for Cancer Research (New York City) for the Second Year in a Row October 18, 2017 11:31am Comments Share: The … 100% of the proceeds from the run go directly to Memorial Sloan Kettering Cancer Center for Cancer Research. “I know cancer has and will continue to affect us all until we find a cure, so …

Baylor College of Medicine

OncLive® Presents Eight State of the Science Summit™ Meetings in February | Business Wire | 1/28/2020

… Feb. 5 at 5 p.m. in New York City. The summit will be chaired by Yelena Y. Janjigian, M.D., of Memorial Sloan Kettering Cancer Center. Lung Cancer — Feb. 11 at 5 p.m. in Los Angeles … summit will be co-chaired by Benjamin Musher, M.D., of Baylor College of Medicine and Shubham Pant, M.D., of The University of Texas MD Anderson Cancer Center. Genitourinary Cancers — Feb. 27 at 5 p.m. in …

Cleveland Clinic

Cancer Media Outlet SurvivorNet Announces $10-million in Series B Funding | PR Newswire | 1/10/2020

… Memorial Sloan Kettering, Cleveland Clinic, The Mayo Clinic, Stanford , and Cedars Sinai. “Health information is the one problem in healthcare that we all suffer from, and nobody has really addressed it. It’s a dramatically underinvested space,” says Alperin. “By building a deeper, higher quality product in this space, we are helping patients ask better questions. With so much incredible progress in cancer right now, doctors have trouble keeping up. So …

Ascension

Tech and health care need their own ‘Hippocratic oath’ - STAT | 12/23/2019

… December 23, 2019 Adobe W hen a whistleblower revealed the details of Project Nightingale , a collaboration between Google and the Ascension health system, he or she also surfaced critical flaws in the ways that health … care have increasingly gravitated towards one another. Think IBM Watson , Memorial Sloan Kettering’s alliance with Paige.AI , and the fall of Outcome Health . These gaffes are exacerbating an already frayed trust between the public and the …

University of Rochester

117 GI physicians to know in 2019 | Becker’s ASC Review | 12/20/2019

Memorial Sloan Kettering Cancer Center in New York CityMark Levstik, MBBCh, of University of Rochester (N.Y.) Medical CenterAllan W. Wolkoff, MD, of Albert Einstein College of Medicine in New York CityStefano Guandalini, MD, of University of Chicago MedicineDaniel Raines, MD, of Louisiana State University Health Sciences Center New OrleansPatrick G. Northup, MD, of UVA Health SystemPeter F. Malet, MD, of NYU Winthrop Hospital in Mineola, N.Y. Fasiha Kanwal, MD, of …

Harvard Medical School

NexImmune Receives IND Clearance for Phase 1/2 Trial in Relapsed / Refractory Multiple Myeloma | Globe Newswire | 12/19/2019

… patients at clinical sites across the United States. Key sites planning to enroll patients include The Dana Farber Cancer Institute, Memorial Sloan Kettering, MD Anderson, and The Karmanos Cancer Institute. The trial is a multi … Paul Richardson, MD, the RJ Corman Professor of Medicine at Harvard Medical School, Clinical Program Leader and Director of Clinical Research at Dana Farber’s Jerome Lipper Multiple Myeloma Center and the clinical trial’s lead investigator …

Northwell Health

MSK to open $1.5B Koch Center for Cancer Care | Crain’s New York Business | 12/10/2019

Memorial Sloan Kettering/Karsten Moran The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center After four years and one very large donation, Memorial Sloan Kettering Cancer Center will start seeing … care, including surgery, interventional radiology, diagnostic imaging and infusion services. Northwell Health announced plans to develop an ambulatory care and cancer center on Third Avenue between East 76th and East 77th streets in August 2018 …

Massachusetts General Hospital

Rafael Holdings Reports First Quarter Fiscal Year 2020 Results | Markets Insider | Business Insider | 12/9/2019

… Massachusetts General Hospital. The initial trial sites were Memorial Sloan Kettering Cancer Center in New York City and City of Hope in Duarte, California ; José Octávio Costa Filho, M.D., joined Rafael Pharma as Co-Chief Medical Officer. He works alongside Timothy Pardee , M.D., Ph.D., who continues as Co-Chief Medical Officer. On August 5 th , 2019 Lipomedix Pharmaceuticals, in which the Company holds a majority interest, announced the addition of …

Mayo Clinic

Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine | PR Newswire | 12/4/2019

Mayo Clinic Cancer Center, Phoenix / Scottsdale, AZ , Jacksonville, FL , and Rochester, MN ; Memorial Sloan Kettering Cancer Center, New York, NY ; Moffitt Cancer Center, Tampa, FL ; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH ; O’Neal Comprehensive Cancer Center at UAB, Birmingham, AL ; Roswell Park Comprehensive Cancer Center, Buffalo, NY ; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St …

Moffitt Cancer Center

Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine | PR Newswire | 12/4/2019

Memorial Sloan Kettering Cancer Center, New York, NY ; Moffitt Cancer Center, Tampa, FL ; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH ; O’Neal Comprehensive Cancer Center at UAB, Birmingham, AL ; Roswell Park Comprehensive Cancer Center, Buffalo, NY ; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO ; St. Jude Children’s Research Hospital/The University of Tennessee Health …

Seattle Cancer Care Alliance, Seattle WA

Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine | PR Newswire | 12/4/2019

… Seattle Cancer Care Alliance, Seattle, WA ; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins , Baltimore, MD ; Robert H. Lurie Comprehensive Cancer Center of Northwestern University , Chicago, IL ; Mayo Clinic Cancer Center, Phoenix / Scottsdale, AZ , Jacksonville, FL , and Rochester, MN ; Memorial Sloan Kettering Cancer Center, New York, NY ; Moffitt Cancer Center, Tampa, FL ; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH ; O’Neal …

Barnes-Jewish Hospital

Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine | PR Newswire | 12/4/2019

Memorial Sloan Kettering Cancer Center, New York, NY ; Moffitt Cancer Center, Tampa, FL ; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH ; O’Neal Comprehensive Cancer Center at UAB, Birmingham, AL ; Roswell Park Comprehensive Cancer Center, Buffalo, NY ; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO ; St. Jude Children’s Research Hospital/The University of Tennessee Health …

University of Texas MD Anderson Cancer Center

Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine | PR Newswire | 12/4/2019

… Comprehensive Cancer Center of Northwestern University , Chicago, IL ; Mayo Clinic Cancer Center, Phoenix / Scottsdale, AZ , Jacksonville, FL , and Rochester, MN ; Memorial Sloan Kettering Cancer Center, New York, NY ; Moffitt Cancer Center, Tampa, FL ; The Ohio … University of Michigan Rogel Cancer Center, Ann Arbor, MI ; The University of Texas MD Anderson Cancer Center, Houston, TX ; University of Wisconsin Carbone Cancer Center, Madison, WI ; Vanderbilt-Ingram Cancer Center, Nashville, TN ; and Yale …

The University of Texas MD Anderson Cancer Center

Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine | PR Newswire | 12/4/2019

… Comprehensive Cancer Center of Northwestern University , Chicago, IL ; Mayo Clinic Cancer Center, Phoenix / Scottsdale, AZ , Jacksonville, FL , and Rochester, MN ; Memorial Sloan Kettering Cancer Center, New York, NY ; Moffitt Cancer Center, Tampa, FL ; The Ohio … CO ; University of Michigan Rogel Cancer Center, Ann Arbor, MI ; The University of Texas MD Anderson Cancer Center, Houston, TX ; University of Wisconsin Carbone Cancer Center, Madison, WI ; Vanderbilt-Ingram Cancer Center, Nashville, TN ; and …

Meridian Health

Hackensack Meridian Health Invests in Adaptive Phage Therapeutics, Aiming to Kill ‘Superbugs’ as Part of Bear’s Den Innovation Program | PR Newswire | 12/4/2019

EDISON, N.J. Hackensack Meridian Health has invested in the clinical-stage biotechnology company Adaptive Phage Therapeutics (APT), as part of the health network’s successful innovation program, the Bear’s Den. APT is taking aim at the … campus in Nutley and Clifton . Additionally, the network partnered with Memorial Sloan Kettering Cancer Center to find more cures for cancer faster while ensuring that patients have access to the highest quality, most individualized cancer …

Hackensack University Medical Center

Hackensack Meridian Health Invests in Adaptive Phage Therapeutics, Aiming to Kill ‘Superbugs’ as Part of Bear’s Den Innovation Program | PR Newswire | 12/4/2019

… life-enhancing care. Hackensack Meridian Health comprises 17 hospitals from Bergen to Ocean counties, which includes three academic medical centers – Hackensack University Medical Center in Hackensack , Jersey Shore University Medical Center in Neptune , JFK Medical … campus in Nutley and Clifton . Additionally, the network partnered with Memorial Sloan Kettering Cancer Center to find more cures for cancer faster while ensuring that patients have access to the highest quality, most individualized cancer …

Hackensack University Medical Center, Hackensack NJ

Hackensack Meridian Health Invests in Adaptive Phage Therapeutics, Aiming to Kill ‘Superbugs’ as Part of Bear’s Den Innovation Program | PR Newswire | 12/4/2019

… life-enhancing care. Hackensack Meridian Health comprises 17 hospitals from Bergen to Ocean counties, which includes three academic medical centers – Hackensack University Medical Center in Hackensack , Jersey Shore University Medical Center in Neptune , JFK Medical … campus in Nutley and Clifton . Additionally, the network partnered with Memorial Sloan Kettering Cancer Center to find more cures for cancer faster while ensuring that patients have access to the highest quality, most individualized cancer …

Maimonides Medical Center

Top Women in Metro New York Foodservice & Hospitality 2020 | 12/4/2019

Maimonides Medical Center • Laurelton, NY Stephanie Giraulo • St. Charles Hospital • Port Jefferson, NY Dr. Carol Letzter • Textured Food Innovations • Carle Place, NY Veronica McLymont • Memorial Sloan Kettering Cancer Center • New York, NY Angela O’Neil • Hunterdon Medical Center • Flemington, NJ Doris V. O’Neil • Golden Gate Rehab & Health Care Center • Trenton, NJ Tatanisha Peets • Memorial Sloan Kettering • New York, NY Tatanisha Peets has touched many lives. As part of the food and …

Columbia University Medical Center

Investigating Breast Cancer: BCRF Symposium & Awards Luncheon | 12/3/2019

… Columbia University Medical Center. Dr. Neil Iyengar of Memorial Sloan Kettering Cancer Center. Dr. Judy Garber, of Dana-Farber Cancer Institute. Dr. Garber also serves as BCRF Scientific Director. The panel was moderated by BCRF’s Founding Scientific Director Dr. Larry Norton of Memorial Sloan Kettering Cancer Center. We’ll have our regular episode of Investigating Breast Cancer in the next weeks. Now, here is Dr. Larry Norton and BCRF’s 2019 Symposium …

UPMC

Bladder cancer drug shortage has ‘caused deaths,’ UPMC urologist says | Becker’s Hospital Review | 12/2/2019

Memorial Sloan Kettering Cancer Center have changed their policies on administering the drug to prioritize newly diagnosed patients. In the case of BCG, “the shortage has definitely led to poor outcomes in bladder cancer patients,” UPMC urologist Dr. Davies said. “You just get more recurrences. So that means you have to have more surgeries, you have to come back to the doctor to be screened more. It’s not a question …

Massachusetts General Hospital, Boston MA

Rafael Pharmaceuticals Announces Expansion of Phase 2 Trial of CPI-613® (devimistat) for Patients with Relapsed or Refractory Burkitt’s Lymphoma/Leukemia to Massachusetts General Hospital in Boston | Globe Newswire | 12/2/2019

Massachusetts General Hospital in Boston starting this month. The trial is currently underway at Memorial Sloan Kettering Cancer Center in New York City and at City of Hope in Duarte, California. “Burkitt’s lymphoma is a rare disease, with approximately 1,200 people in the United States diagnosed annually, so treatment options for these patients are very limited,” said Sanjeev Luther, President and CEO of Rafael Pharmaceuticals. “The disease is highly aggressive …

Hospital for Special Surgery

Is Traditional Chinese Medicine Use Associated with Worse Patient-reported Outcomes among Chinese American Rheumatology Patients? | 12/1/2019

Memorial Sloan Kettering Cancer Center; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery; Department of Medicine, Weill Cornell Medicine, New York, New York, USA . Previous Next Abstract Objective. Chinese Americans are a fast-growing immigrant group with more severe rheumatic disease manifestations than whites and often a strong cultural preference for traditional Chinese medicine (TCM). We aimed to examine TCM use patterns and association with patient-reported outcomes …

Beth Israel Deaconess Medical Center

Visiongain Report Looks at Opportunities within the $1.8bn Acute Myeloid Leukaemia Market | PR Newswire | 11/28/2019

… Organizations Mentioned in the Report American Cancer Organization Baylor Scott and White Research Institute Benaroya Research Institute at Virginia Mason Beth Israel Deaconess Medical Center Breslin Cancer Center Center for Blood Disorders and Stem Cell … College of Wisconsin Cancer Center Medizinische Klinik und Poliklinik I Memorial Sloan Kettering Cancer Center Michigan State University Nantes University Hospital National Cancer Institute New Jersey Hematology Oncology Associates Northwestern University Ochsner Medical Center Penn …

Leiden University Medical Center

Genome Editing Services, World Markets to 2030: Focus on CRISPR - The Most Popular Genome Manipulation Technology Tool | The Wapakoneta Daily News | 11/28/2019

Leiden University Medical Center Leland Stanford Junior University Leucid Bio LifeEDIT Ligandal Liminatus Pharma Lion TCR Living Pharma Locus Biosciences LogicBio Therapeutics Lokon Pharma Lonza Loop Genomics Loyola University LubioScience Lucigen Ludwig Cancer Research Lysogene MabVax Therapeutics Macrogen Mammoth Biosciences Marino Biotechnology Marsala Biotech Massachusetts General Hospital Massachusetts Institute of Technology MaxCyte Mayo Clinic MD Anderson Cancer Center Medical College of Wisconsin Medigene MedImmune Medisix Therapeutics MeiraGTx Memorial Sloan Kettering

NYU Langone Health

Choosing Frontline Regimens in Different RCC Patient Populations and Future Promise of Novel Therapies | 11/27/2019

… cancer.” Cho, an associate professor in the Department of Medicine and director of the Phase I Drug Development Program at NYU Langone Health in New York, New York, will speak during his presentation, “Next-Generation … the Jack and Dorothy Byrne Chair in Clinical Oncology, at Memorial Sloan Kettering Cancer Center in New York, New York, and colleagues in the New England Journal of Medicine .6 Motzer will also be speaking …

Baptist Health South Florida

Bethesda Health Physician Group Welcomes Fellowship-Trained Endocrine Surgeon Jessica L. Buicko, M.D., to Its Team | 11/27/2019

… has joined Bethesda Health Physician Group, a premier physician group that provides high-quality medical care and is part of Baptist Health South Florida. Dr. Buicko treats a range of disorders impacting the body’s endocrine … surgery at New York-Presbyterian/Weill Cornell Medical Center and Memorial Sloan Kettering Cancer Center. She also received advanced training in breast surgical oncology and minimally invasive surgery, including both robotic and laparoscopic surgery. Dr …

Health Net

117 GI physicians to know in 2019 | Becker’s ASC Review | 12/20/2019

… Health Network in Bethlehem, Pa.Neeral Shah, MD, of UVA Health System in Charlottesville, Va.Sang H. Kim, MD, of NewYork-Presbyterian Queens in New York CitySteven Fine, MD, of MetroWest Medical Center in Framingham, Mass. Arkady Broder, MD, of St. Peter’s Healthcare System in New Brunswick, N.J.Joseph Polito, MD, of Albany (N.Y.) Gastroenterology AssociatesRobert C. Kurtz, MD, of Memorial Sloan Kettering Cancer Center in New York CityMark Levstik, MBBCh, of University …

Breast cancer survivor charts new normal | 11/2/2019

… of see a few things, and we would like you to come back and we’re going to do another mammogram and we’re going to do a sonogram.” Ellen asked the University of Vermont Health Network, Champlain Valley Physicians Hospital tech what she saw, and the tech pointed to splotches, calcium deposits, not uncommon in a woman her age. NO LONGER HIDDEN Dr. Curt M. Snyder, a Women’s Imaging radiologist, looked …

Aetna

Global Genitourinary Partnering Deal Trends, Players and Financials Directory 2014-2019 | PR Newswire | 10/24/2019

… deals by technology type 2014 to 2019 Companies Mentioned A1M Pharma Acerus Aceto Corporation Acon Labs Acurx Pharmaceuticals AEterna Zentaris Aetna Akebia Therapeutics AKESOgen Alivio Therapeutics Allegis Holdings Allergan Alnylam Pharmaceuticals AM-Pharma American Diabetes … Medison Pharma Medline Industries Medpace Medtronic Meiji Seika Melinta Therapeutics Memorial Sloan Kettering Cancer Center Menarini Merck Sharpe & Dohme Metabolon Metamark Genetics Methuselah Foundation MicrobeDx Minnesota Medical Mironid Mission Pharmacal Mitobridge Mitsubishi Tanabe Pharma Murdoch …

Claus Torp Jensen | 10/24/2019

Newswise — October 14, 2019, NEW YORK CITY — Memorial Sloan Kettering Cancer Center (MSK) today announced that Claus Torp Jensen, PhD, has joined the institution as its first Chief Digital Officer and Head of Technology. His recruitment follows an expansive national search to identify a leader with the vision and experience to lead MSK’s digital transformation. Dr. Jensen joins MSK from CVS Health and Aetna, where he served as chief technology …

Meridian Health Plan

Hackensack Meridian Health plans acquisition of Englewood Health | FierceHealthcare | 10/16/2019

New Jersey-based nonprofit health system Hackensack Meridian Health plans to acquire Englewood Health. Hackensack committed a $400 million capital investment in Englewood as part of a definitive agreement signed by the boards of both … it to benefit from Hackensack’s partnership with institutions such as Memorial Sloan Kettering Cancer Center and Carrier Clinic , New Jersey’s largest behavioral health provider, officials said. The decision is part of a necessary evolution, said …

Hackensack Meridian Health plans acquisition of Englewood Health | FierceHealthcare | 10/16/2019

New Jersey-based nonprofit health system Hackensack Meridian Health plans to acquire Englewood Health. Hackensack committed a $400 million capital investment in Englewood as part of a definitive agreement signed by the boards of both … it to benefit from Hackensack’s partnership with institutions such as Memorial Sloan Kettering Cancer Center and Carrier Clinic , New Jersey’s largest behavioral health provider, officials said. The decision is part of a necessary evolution, said …

Cigna

Cigna and MSK Start Value-Based, Coordinated Cancer Care Program | HealthPayer Intelligence | 8/5/2019

Value-Based Care News Cigna and MSK Start Value-Based, Coordinated Cancer Care Program The partnership, part of Cigna Collaborative Care initiative, relies on a value-based, coordinated care arrangement to streamline medical and insurance services. Source: Cigna By Kelsey Waddill August 05, 2019 - Cigna and Memorial Sloan Kettering (MSK) Cancer Center are collaborating to provide members with value-based, coordinated cancer care, Cigna announced . “We’re pleased to partner with …

Cigna, Memorial Sloan Kettering team up to coordinate care for chemotherapy patients | FierceHealthcare | 7/27/2019

RELATED: A look at Cigna’s international NGO plans “Collaborating with healthcare providers is one of the most important ways we can improve health outcomes and supports our goal of providing high-quality, affordable care to … McCormick, R.N., senior vice president and chief nursing officer at Memorial Sloan Kettering, said providing these services through a nurse coordinator offers significant opportunities for more streamlined and personal care, because nurses are on the …

Fred Hutchinson

The Parker Institute for Cancer Immunotherapy Awards $2.75 Million to Support Six Early Career Researchers from Leading Research Institutions | PR Newswire | 2/26/2020

… of immunotherapy experts. PICI selected the early career researchers from leading research institutions in its network, including City of Hope, Memorial Sloan Kettering Cancer Center, the Perelman School of Medicine at the University of Pennsylvania … other institutions, including City of Hope, Dana-Farber Cancer Institute, Fred Hutchinson Cancer Research Center, Icahn School of Medicine at Mount Sinai, Institute for Systems Biology and Washington University School of Medicine in St. Louis …

Sandra Horning

Cut-rate Prices Are Strategy of Biotech Startup EQRx | Managed Care Magazine | 1/15/2020

Alex Borisy has raised $200 million and has Peter Bach, Sandra Horning onboard January 15, 2020 Peter Wehrwein A well-known and respected Boston biotech entrepreneur has raised $200 million for a new startup company … FierceBiotech dubbed EQRx “JetBlue for biopharma.” Peter Bach , MD, of Memorial Sloan Kettering and Sandra Horning , the former chief medical officer of Roche, are co-founders and advisers …

Antoine Yver

ENHERTU® Approved in the U.S. for HER2 Positive Unresectable or Metastatic Breast Cancer Following Two or More Prior Anti-HER2-Based Regimens | Business Wire | 12/21/2019

… two HER2 targeted regimens in the metastatic setting, there are limited treatment options,” said Shanu Modi, MD, Breast Medical Oncologist, Memorial Sloan Kettering Cancer Center. “ENHERTU has the potential to become a new standard of … treatment for patients with HER2 positive metastatic breast cancer,” said Antoine Yver, MD, MSc, Executive Vice President and Global Head, Oncology R&D, Daiichi Sankyo. “Since the beginning of our clinical trial program four years …

Kenji Yasukawa

FDA Grants Accelerated Approval to Astellas’ and Seattle Genetics’ PADCEV™ (enfortumab vedotin-ejfv) for People with Locally Advanced or Metastatic Urothelial Cancer, the Most Common Type of Bladder Cancer – Company Announcement - FT.com | Financial Times | 12/19/2019

… TOKYO –(BUSINESS WIRE)–Dec. 18, 2019– Seattle Genetics , Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa , Ph.D., “Astellas”) today announced that the U.S. Food and Drug Administration ( FDA ) granted … E. Rosenberg , M.D., Medical Oncologist, Chief, Genitourinary Medical Oncology Service, Memorial Sloan Kettering Cancer Center in New York . “The PADCEV clinical trial enrolled a range of patients whose cancer was difficult to treat, including those …

Michel Sadelain

Kite Pharma, Juno duke it out in court over megamillion-dollar CAR-T patent | FiercePharma | 12/12/2019

Memorial Sloan Kettering Cancer Center in November 2013, the lawsuit claims. Before that license deal, back in 2007, a scientific collaborator with Kite named Steven Rosenberg posed some questions to Michel Sadelain, one of the inventors of the ‘190 patent, the suit says. Based on Rosenberg’s position as a National Cancer Institute researcher, Sadelain referred his fellow scientist to a 2002 journal article that discussed the patent, the lawsuit suit …

David H. Koch

MSK to open $1.5B Koch Center for Cancer Care | Crain’s New York Business | 12/10/2019

Memorial Sloan Kettering/Karsten Moran The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center After four years and one very large donation, Memorial Sloan Kettering Cancer Center will start seeing patients next month at the David H. Koch Center for Cancer Care, the largest outpatient cancer center in the city, according to MSK. The $1.5 billion, 750,000-square-foot facility, located on East 74th Street …

Kevin Hern

Lilly Presents Interim Clinical Data from LOXO-305 Dose Escalation Trial in B-Cell Leukemias and Lymphomas at the American Society Hematology Annual Meeting | PR Newswire | 12/8/2019

… inhibitors, as well as in patients resistant to BCL2 inhibition,” said Anthony Mato , M.D., director of the CLL Program at Memorial Sloan Kettering Cancer Center and the presenting author. “We observed compelling response rates in … Lauren Cohen; ; (617) 678-2067 – media Dan Budwick; ; (973) 271-6085 – media Kevin Hern; ; (317) 277-1838 – investors SOURCE Eli Lilly and Company Related Links …

Josh Bilenker

Lilly Announces New Leadership and Strategy in Oncology Research and Development | Markets Insider | Business Insider | 12/5/2019

Josh Bilenker , M.D., Jacob Van Naarden , and Nisha Nanda , Ph.D., and will report into Daniel Skovronsky , M.D., Ph.D., Lilly’s chief scientific officer and president of Lilly Research Laboratories. Lilly today also announced that David Hyman , M.D. will join the leadership team as chief medical officer of the new organization, beginning in January 2020 . Dr. Hyman currently serves as chief of the Early Drug Development Service at Memorial Sloan Kettering Cancer …

Laura Wood

Global Proteomics Partnering Terms and Agreements 2014-2019 - Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indication | The Wapakoneta Daily News | 12/4/2019

… Luxembourg Institute of Health Mariel Therapeutics Massachusetts General Hospital MD Anderson Cancer Center Medgenics Medical University of South Carolina MedImmune Memorial Sloan Kettering Cancer Center Merck and Co Metabolon Moderna Therapeutics Mologic MRM Proteomics Munich … Research services providing focused, comprehensive and tailored research. CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call …

Joseph M. Sanzari

Hackensack Meridian Health Invests in Adaptive Phage Therapeutics, Aiming to Kill ‘Superbugs’ as Part of Bear’s Den Innovation Program | PR Newswire | 12/4/2019

… University Medical Center in Hackensack , Jersey Shore University Medical Center in Neptune , JFK Medical Center in Edison ; two children’s hospitals - Joseph M. Sanzari Children’s Hospital in Hackensack , K. Hovnanian Children’s Hospital in Neptune ; nine community … campus in Nutley and Clifton . Additionally, the network partnered with Memorial Sloan Kettering Cancer Center to find more cures for cancer faster while ensuring that patients have access to the highest quality, most individualized cancer …

Helen Diller

Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine | PR Newswire | 12/4/2019

… Comprehensive Cancer Center of Northwestern University , Chicago, IL ; Mayo Clinic Cancer Center, Phoenix / Scottsdale, AZ , Jacksonville, FL , and Rochester, MN ; Memorial Sloan Kettering Cancer Center, New York, NY ; Moffitt Cancer Center, Tampa, FL ; The Ohio … UC San Diego Moores Cancer Center, La Jolla, CA ; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA ; University of Colorado Cancer Center, Aurora, CO ; University of Michigan Rogel Cancer Center, Ann Arbor, MI …

Melinda Gates

Asia’s 2019 Heroes Of Philanthropy: Catalysts For Change | Forbes | 12/3/2019

… Reserve. The same year she became the first woman from China to sign the Giving Pledge created by Bill Gates, Melinda Gates and Warren Buffett. Marcus Blackmore, 74 Executive Director, Blackmores Australia Blackmore donated A … oncology. The couple also pledged $2 million recently to the Memorial Sloan Kettering Cancer Center in New York to establish the Mazumdar-Shaw International Clinical Fellowships. Mazumdar-Shaw, who signed the Giving Pledge in 2016 …

Bill Gates

Asia’s 2019 Heroes Of Philanthropy: Catalysts For Change | Forbes | 12/3/2019

… Fanjingshan National Reserve. The same year she became the first woman from China to sign the Giving Pledge created by Bill Gates, Melinda Gates and Warren Buffett. Marcus Blackmore, 74 Executive Director, Blackmores Australia Blackmore … oncology. The couple also pledged $2 million recently to the Memorial Sloan Kettering Cancer Center in New York to establish the Mazumdar-Shaw International Clinical Fellowships. Mazumdar-Shaw, who signed the Giving Pledge in 2016 …

Warren Buffett

Asia’s 2019 Heroes Of Philanthropy: Catalysts For Change | Forbes | 12/3/2019

… year she became the first woman from China to sign the Giving Pledge created by Bill Gates, Melinda Gates and Warren Buffett. Marcus Blackmore, 74 Executive Director, Blackmores Australia Blackmore donated A$10 million ($7.2 … oncology. The couple also pledged $2 million recently to the Memorial Sloan Kettering Cancer Center in New York to establish the Mazumdar-Shaw International Clinical Fellowships. Mazumdar-Shaw, who signed the Giving Pledge in 2016 …

Elizabeth Warren

Conservative think tank says ad slamming the wealth tax is not about defending the wealthy | Yahoo News | 11/29/2019

There’s a new ad campaign slamming Sen. Elizabeth Warren and Sen. Bernie Sanders’ call for a ‘wealth tax’, urging them not to ‘punish success.’ Conservative think tank Employment Policies Institute is behind the campaign that … or it’s gone to fund a new cancer center like Memorial Sloan Kettering,” he said. According to Chronicle of Philanthropy through an analysis of public disclosures, that figure is actually $7.8 billion from America’s 50 …

Bernie Sanders

Conservative think tank says ad slamming the wealth tax is not about defending the wealthy | Yahoo News | 11/29/2019

There’s a new ad campaign slamming Sen. Elizabeth Warren and Sen. Bernie Sanders’ call for a ‘wealth tax’, urging them not to ‘punish success.’ Conservative think tank Employment Policies Institute is behind the campaign that … or it’s gone to fund a new cancer center like Memorial Sloan Kettering,” he said. According to Chronicle of Philanthropy through an analysis of public disclosures, that figure is actually $7.8 billion from America’s 50 …

Elon Musk

Conservative think tank says ad slamming the wealth tax is not about defending the wealthy | Yahoo News | 11/29/2019

… partner at a public relations firm Berman and Company. “It’s more sending a message to the next Mark Zuckerberg, or Elon Musk, the next Bill Gates or whoever else that we value entrepreneur activity and … or it’s gone to fund a new cancer center like Memorial Sloan Kettering,” he said. According to Chronicle of Philanthropy through an analysis of public disclosures, that figure is actually $7.8 billion from America’s 50 …

Mark Zuckerberg

Conservative think tank says ad slamming the wealth tax is not about defending the wealthy | Yahoo News | 11/29/2019

… Saltsman is also partner at a public relations firm Berman and Company. “It’s more sending a message to the next Mark Zuckerberg, or Elon Musk, the next Bill Gates or whoever else that we value … or it’s gone to fund a new cancer center like Memorial Sloan Kettering,” he said. According to Chronicle of Philanthropy through an analysis of public disclosures, that figure is actually $7.8 billion from America’s 50 …

Jeff Bezos

Conservative think tank says ad slamming the wealth tax is not about defending the wealthy | Yahoo News | 11/29/2019

… you have an idea that makes it big,” he said. The ad featured images of ultra-wealthy business figures including Jeff Bezos, Warren Buffett, Elon Musk, Mark Cuban, Oprah Winfrey and Mark Zuckerberg along with … or it’s gone to fund a new cancer center like Memorial Sloan Kettering,” he said. According to Chronicle of Philanthropy through an analysis of public disclosures, that figure is actually $7.8 billion from America’s 50 …

Priscilla Chan

Conservative think tank says ad slamming the wealth tax is not about defending the wealthy | Yahoo News | 11/29/2019

… business figures including Jeff Bezos, Warren Buffett, Elon Musk, Mark Cuban, Oprah Winfrey and Mark Zuckerberg along with his wife Priscilla Chan. Saltsman believes wealthy Americans do not hoard piles of money in their basement … or it’s gone to fund a new cancer center like Memorial Sloan Kettering,” he said. According to Chronicle of Philanthropy through an analysis of public disclosures, that figure is actually $7.8 billion from America’s 50 …

Terry Fox

Worldwide Markets for Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing, Forecast to 2030 - Robust Pipeline of Therapy Candidates and Technical Advances Projected to Drive the Market | Benzinga | 11/27/2019

… Cancer Research UK Capsugel Carnegie Institution for Science Celgene Cell and Gene Therapy Catapult Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center Celladon Cellectis Cellular Biomedicine Group Celonic Center for Biomedicine & Genetics … Synthace Synthetic Genomics System Biosciences T. Rowe Price Associates Tecrea Terry Fox Laboratory Texas A&M University The Finnish Fair Foundation The Goldyne Savad Institute of Gene Therapy, Hadassah Medical Organization The Jarvis Lab The …

Alex Azar

How a billionaire couple greased the skids for Nancy Pelosi’s drug pricing bill | STAT | 11/26/2019

… brazen campaign to sabotage Trump’s signature drug pricing plan The $4.4 million grant the Arnolds awarded to Bach’s team at Memorial Sloan Kettering Cancer Center was among the first of over a dozen multimillion-dollar … Arnold secured a face-to-face meeting with health secretary Alex Azar, the former Eli Lilly executive who has spearheaded much of the Trump administration’s drug pricing work. The same day, the peer-reviewed academic …

Ron Wyden

How a billionaire couple greased the skids for Nancy Pelosi’s drug pricing bill | STAT | 11/26/2019

… brazen campaign to sabotage Trump’s signature drug pricing plan The $4.4 million grant the Arnolds awarded to Bach’s team at Memorial Sloan Kettering Cancer Center was among the first of over a dozen multimillion-dollar … panel following remarks from Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.), authors of a bipartisan drug pricing proposal in the Senate, and he has testified this year both before the Senate Finance …

Nancy Pelosi

How a billionaire couple greased the skids for Nancy Pelosi’s drug pricing bill | STAT | 11/26/2019

… during the World Series. In September, a prominent former lawmaker contracted by the couple’s advocacy arm vocally endorsed House Speaker Nancy Pelosi’s marquee drug pricing legislation. And in 2019 alone, at least eight researchers and … 4.4 million grant the Arnolds awarded to Bach’s team at Memorial Sloan Kettering Cancer Center was among the first of over a dozen multimillion-dollar checks the Arnolds would write in the name of lowering …

Antoni Ribas

BRAF/MEK Inhibitor Combo Produces Benefits in Advanced Melanoma | 11/26/2019

… at 5 years in BRAF-mutated melanoma by Vicki Brower, CME Writer, MedPage Today November 26, 2019 MedpageToday Study Authors: Antoni Ribas, Adil Daud, et al. Target Audience and Goal Statement: Oncologists, dermatologists, primary care … 33.1%) at 5 years. ASCO discussant Paul Chapman, MD, of Memorial Sloan Kettering Cancer Center in New York City, focused on the next steps and unresolved issues raised by the combination studies in his discussion …